A team led by Janet Rubin at the University of North Carolina School of Medicine recently found a novel method to push stem cells into forming bone.
Researchers in Australia have used stem cells from human skin to create "mini-kidneys" that could be used to test new renal drugs and possibly, just possibly, also be used to bioengineer replacement kidneys in the future.
Mitsubishi Chemical Holdings unit Life Science Institute has bought multilineage-differentiating stress-enduring (Muse) stem cell firm Clio for more than 1 billion yen ($8 million), according to a press release. Life Sciences in a Japanese language release on May 14 said Clio will become a wholly-owned subsidiary.
South Korea's Green Cross Holdings and POSCO Capital joined to buy a $7.5 million stake in U.S.-based Juventas Therapeutics, pushing a regenerative and biologics growth strategy that has seen recent deals in China and Russia.
The new president of Japan's Riken research institute vowed to enter into partnerships with more businesses as part of his plan for reform of the institution hit by a scandal over its stem cell research.
China health authorities have proposed some new regulations for conducting stem-cell clinical trials in the country, one requiring that a 30-year archive of the clinical records of stem-cell donors and patients be maintained.
Scientists at the Scripps Research Institute say they've identified an enzyme necessary for maintaining the stability of hematopoietic stem cells.
Researchers in Japan said they have been able to stop the deterioration associated with muscular dystrophy by creating stem cells and implanting them in a mouse.
A group of bioengineers at UC Berkeley has been hard at work hatching a new "heart-on-a-chip" technology that aims to offer researchers a better, less expensive way to develop new drugs.
Investigators say that they've identified a pathway that can be used to target brain tumor stem cells, adding to potential therapeutic strategies for the aggressive disease glioblastoma.